Found 473 clinical trials
A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Study To Evaluate The Safety And Efficacy Of Oral Difelikefalin In Advanced Chronic Kidney Disease Subjects With Moderate-To-Severe Pruritus And Not On Dialysis With An Up To 52-Week Long-Term Extension
Global: 400 male and female subjects (200 per treatment group) with advanced CKD who are not on dialysis will be enrolled in the study. The sample size may be increased to 550 subjects based on
- 0 views
- 29 Sep, 2022
- 1 location
Diabetic Kidney Disease
We are seeking adult participants with Type 2 Diabetic Kidney Disease for a clinical research study to evaluate the effectiveness of two study medications. This study is assessing whether the combination of the two study medications is superior than one medication alone in reducing protein in the urine, therefore, helping …
- 0 views
- 26 Jan, 2023
- 1 location
- 14 views
- 26 Jan, 2023
- 1 location
Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).
Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).
- 466 views
- 25 Mar, 2021
- 1 location
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION
CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE
- 374 views
- 25 Mar, 2021
- 1 location
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION
CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE
- 270 views
- 25 Mar, 2021
- 1 location
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
INDICATION: Treatment of hypertension in patients with uncontrolled hypertension and chronic kidney disease (CKD)
- 0 views
- 29 Sep, 2022
- 1 location
Kidney Disease in Type 2 Diabetics
Kidney Disease in Type 2 Diabetics
- 1362 views
- 25 Mar, 2021
- 1 location
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
- 555 views
- 25 Mar, 2021
- 1 location
